尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
THE THIRD QUARTER RESULTS OF 2014
2014-10-27
Overseas Regulatory Announcement_3_
2014-10-27
Overseas Regulatory Announcement_2_
2014-10-27
Overseas Regulatory Announcement_1_
2014-10-27
Overseas Regulatory Announcement
2014-10-27
CONTINUING CONNECTED TRANSACTIONS
2014-10-27
Announcement Notice of Board Meeting
2014-10-15
Overseas Regulatory Announcement
2014-10-09
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2014-09-30
DISCLOSEABLE AND CONNECTED TRANSACTIONIN RELATION TO XINCAT PHARMACEUTICAL ACQUI
2014-09-30
<
...
58
59
60
61
62
63
64
...
>